Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early rehabilitation program in total nephrectomy for kidney cancer
2006-006445-13Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of gabapentin, ketamine and ropivacaine in renal cell carcinoma (RCC), sponsored by Centre Hospitalier Universitaire. Primary endpoint: Length of hospital stay. Started Mar 2007; status: completed.
02
Drugs
gabapentinketamineropivacaine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2006-006445-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006445-13.